PRIMARY STUDY
Chemosensitizing Properties of β-Caryophyllene and β-Caryophyllene Oxide in Combination with Doxorubicin in Human Cancer Cells
Key Findings: Resulting data showed that β-caryophyllene and β-caryophyllene oxide may play a potential role as a novel chemosensitizing agents for doxorubicin chemotherapy and to re-sensitize cancer-resistant cells.
Type of Study: Laboratory Study
Study Result: Positive
Study Location(s): Germany, Italy
Year of Pub: 2017
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Terpenes Studied: ß-Caryophyllene
